[1]段炼,李险峰.甲状腺相关眼病与生长抑素受体显像[J].国际放射医学核医学杂志,2005,29(3):108-111.
　DUAN Lian,LI Xian-feng.Thyroid associated ophthalmopathy and somatostatin receptor scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(3):108-111.
点击复制

甲状腺相关眼病与生长抑素受体显像(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
29
期数:
2005年第3期
页码:
108-111
栏目:
核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Thyroid associated ophthalmopathy and somatostatin receptor scintigraphy
作者:
段炼;  李险峰
030001 太原, 山西医科大学第一医院核医学科030001太原
Author(s):
DUAN Lian;  LI Xian-feng
Department of Nuclear Medicine, the First Hospital Affiliated to Shanxi Medical University, Taiyuan 030001, China
关键词:
甲状腺相关眼病; 生长抑素受体; 受体显像; 奥曲肽
Keywords:
thyroid associated ophthalmopathy; somatostatin receptor; receptor scintigraphy; octr- eotide
分类号:
R817.4
摘要:
甲状腺相关眼病是眼眶最常见的疾病之一,是一种自身免疫性疾病。目前,临床证实免疫抑制剂和眼眶局部放疗对活动期的患者有显著疗效,而对于静止期的患者基本无效。因此,对甲状腺相关眼病患者活动度评定的准确性和客观性关系到患者的治疗方案、疗效及预后,眼眶生长抑素受体显像在判断其活动度及评价治疗效果方面有重要的意义。
Abstract:
Thyroid associated ophthalmopathy(TAO) is one of the most familiar disease in orbit and an autoimmune disorder. At present, it was proved that the patients with active TAO would benefit from immuno-suppressive therapy or retrobulbar radiotherapy, but inactive TAO. The veracity and objectivity of TAO activity degree assessment determine patient’s treatment project, curative effect and prognosis. There is important significance of jugging activity and evaluating curative effect by somatostatin receptor scintigraphy in TAO.

参考文献/References:

1 Weetman AP. Thyroid-associated disease pathophysiology[J].Lancet, 1991, 338:25.
2 Weetman AP. Gaves’disease[J]. N Engl J Med, 2000, 343:1236-1248.
3 Anastaia P, Joanna ML,Virginia C, et al. T cells and fibroblasts in affected extraocular muscles in ealy and late thyroid associated ophthalmopathy[J]. J Br Ophthlnol, 2000, 84:517-522.
4 Bahn RS. Understanding the immunology of Graves’ophthalmopathy. Is it an autoimmune disease?[J]. J Endocrinol Metab Clin North Am, 2000, 29(2):287-296.
5 Tomer Y, Greenberg D, Barbesino G, et al. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production[J]. J Clin Endocrinol Metab, 2001,86:1687-1693.
6 Weetman AP. Autoimmune thyroid disease:propagation and progress[J]. Eur J Endocrinol, 2003, 148(1):1-9.
7 Burggasser G, Hurtl I, Hauff W, et al. Orbital scintigTaphy with the somatostatin receptor tracer 99mTc-P829 in patients with Graves’disease[J]. J Nucl Med, 2003, 44(10):1547-1555.
8 Cascini GL, Cuccurullo V, Rambaldi PF, et al. Immunological imaging using tagged octreotide[J]. Minerva Endocrinol, 2001, 26(3):129-133.
9 Pasquali D, Vassallo P, Esposito D, et al. Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves’ophthalmopathy[J]. J Mol Endocrinol, 2000, 25(1):63-71.
10 Gerding MN, Zant FM, Royent EA, et al. Octretide- scintigraphy is a disease activity parameter in Graves’ophthalmopathy[J]. Clin Endocrinol, 2002, 50(3):373-379.
11 Kainz H, Bale R, Donnemiller E, et al. Image fusion analysis of 99Tcm-HYNIC-Octreotide scintigraphy and CT/MRI in patients with thyroid-associated ophthalmopathy:the importance of the lacrimal gland[J]. Eur J Nucl Med, 2003, 30:1155-1159.
12 Doumas AS, Krassas G, Kaltsas T, et al. Imaging somatostatin receptor activity in patients with active thyroid eye disease using Tc-99m depreotide[J]. Clin Nucl Med, 2003, 28(5):439-440.
13 Prumme MF, Gerding MN, Zonneveld FW, et al. The usefulness of quantitative orbital MRI in Graves’ophthalmopathy[J]. Clin Endocrinol, 2001, 54:205-209.
14 Virgolini I, Tranb T, Novotny C, et al. Radiolabeled peptides in oncology[J]. Nucl Med Commun, 2000, 21:562-563.

相似文献/References:

[1]郭睿,晋建华.99mTc-depreotide生长抑素受体显像的临床应用研究[J].国际放射医学核医学杂志,2007,31(3):154.
　GUO Rui,JIN Jian-hua.The clinical application and study of 99mTc-depreotide somatostatin receptor imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(3):154.
[2]王利伟,王自正,顾建平,等.孤立性肺结节的影像学研究进展[J].国际放射医学核医学杂志,2005,29(6):248.
　WANG Li-wei,WANG Zi-zheng,GU Jian-ping,et al.The development in imaging of the solitary pulmonary nodules[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(3):248.
[3]赵德善.放射性核素标记生长抑素类似物在淋巴瘤中的应用[J].国际放射医学核医学杂志,2004,28(5):206.
　ZHAO De-shan.The role of radionuclide-labeled somatostatin analogues in lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(3):206.

备注/Memo

备注/Memo:
收稿日期:2004-08-20。
更新日期/Last Update: 1900-01-01